FormsNet3 - Blank Form


 
 
Sequence Number:    

 
 
Date Received: __ __ __ __ - __ __- __ __  

 
 
CIBMTR Center Number:    

 
 
CIBMTR Recipient ID:    

 
 
Today's Date: __ __ __ __ - __ __- __ __  

 
 
Date of HSCT for which this form is being completed: __ __ __ __ - __ __- __ __  

 

HSCT type (check all that apply): 

 
  

gfedcb
Autologous

 
 

  
gfedcb

Allogeneic, unrelated

 
 

  
gfedcb

Allogeneic, related

 
 

  
gfedcb

Syngeneic (identical twin)

 

Product type (check all that apply): 

 
  

gfedcb
Marrow

 
 

  
gfedcb

PBSC

 
 

  
gfedcb

Cord blood

 
 

  
gfedcb

Other product

 
 
Specify:    

 
 

  
gfedcb

If this is a report of a second or subsequent transplant, check here and continue with question 78.

 
 
1  What was the date of diagnosis of Langerhans cell histiocytosis (LCH)? __ __ __ __ - __ __- __ __  

 

Specify the known organ involvement at diagnosis: 
 

2  Bone

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

3  Confirmed by biopsy?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

4  If confirmed by biopsy, histologic diagnosis:

    
 nmlkji

Presumptive  
 nmlkji

Designated  
 nmlkji

Definitive  

 
 

5  Bone Marrow

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

6  Confirmed by biopsy?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

7  If confirmed by biopsy, histologic diagnosis:

    
 nmlkji

Presumptive  
 nmlkji

Designated  
 nmlkji

Definitive  

 
 

8  Central nervous system

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

9  Confirmed by biopsy?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

10  If confirmed by biopsy, histologic diagnosis:

    
 nmlkji

Presumptive  
 nmlkji

Designated  
 nmlkji

Definitive  

  Key Fields 

Disease Diagnosis Information Questions: 1 - 77

Form 2040 R2.0: Langerhans Cell Histiocytosis Pre-HSCT Data  
Center:  CRID: 

                CIBMTR Form 2040 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 1 / 6



 
 

11  Gastrointestinal tract

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

12  Confirmed by biopsy?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

13  If confirmed by biopsy, histologic diagnosis:

    
 nmlkji

Presumptive  
 nmlkji

Designated  
 nmlkji

Definitive  

 
 

14  Liver

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

15  Confirmed by biopsy?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

16  If confirmed by biopsy, histologic diagnosis:

    
 nmlkji

Presumptive  
 nmlkji

Designated  
 nmlkji

Definitive  

 
 

17  Lung

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

18  Confirmed by biopsy?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

19  If confirmed by biopsy, histologic diagnosis:

    
 nmlkji

Presumptive  
 nmlkji

Designated  
 nmlkji

Definitive  

 
 

20  Lymph nodes

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

21  Confirmed by biopsy?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

22  If confirmed by biopsy, histologic diagnosis:

    
 nmlkji

Presumptive  
 nmlkji

Designated  
 nmlkji

Definitive  

 
 

23  Skin

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

24  Confirmed by biopsy?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

25  If confirmed by biopsy, histologic diagnosis:

    
 nmlkji

Presumptive  
 nmlkji

Designated  
 nmlkji

Definitive  

 
 

26  Spleen

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

27  Confirmed by biopsy?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

28  If confirmed by biopsy, histologic diagnosis:

    
 nmlkji

Presumptive  
 nmlkji

Designated  
 nmlkji

Definitive  

 
 

29  Other organ

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

Form 2040 R2.0: Langerhans Cell Histiocytosis Pre-HSCT Data  
Center:  CRID: 

                CIBMTR Form 2040 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 2 / 6



 
 

30  Confirmed by biopsy?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

31  If confirmed by biopsy, histologic diagnosis:

    
 nmlkji

Presumptive  
 nmlkji

Designated  
 nmlkji

Definitive  

 
 
32  Specify other organ:    

 
 

33  Is a copy of the biopsy report attached?

    
 nmlkji

yes  
 nmlkji

no  

 
 

34  Did the recipient develop diabetes insipidus at any time prior to the preparative regimen?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

35  Was the recipient given treatment for LCH prior to the preparative regimen?

    
 nmlkji

yes  
 nmlkji

no  

 
 
36  Date started therapy: __ __ __ __ - __ __- __ __  

 
 
37  Date stopped therapy: __ __ __ __ - __ __- __ __  

 
 

38  Systemic therapy:

    
 nmlkji

yes  
 nmlkji

no  

  
 
39  Number of cycles    

 
  

gfedcb
Number of cycles unknown / not applicable

 

Treatment: 
 

40  2 CdA (cladribine)

    
 nmlkji

yes  
 nmlkji

no  

 
 

41  6-mercaptopurine (6-MP)

    
 nmlkji

yes  
 nmlkji

no  

 
 

42  Chlorambucil

    
 nmlkji

yes  
 nmlkji

no  

 
 

43  Cyclosporin-A (CsA)

    
 nmlkji

yes  
 nmlkji

no  

 
 

44  Etoposide (VP-16)

    
 nmlkji

yes  
 nmlkji

no  

 
 

45  Steroids

    
 nmlkji

yes  
 nmlkji

no  

 
 

46  Vinblastine (Velban)

    
 nmlkji

yes  
 nmlkji

no  

 
 

47  Other

    
 nmlkji

yes  
 nmlkji

no  

 
 
48  Specify other:    

 
 

49  Radiation Therapy:

    
 nmlkji

yes  
 nmlkji

no  

 
 

50  Bone:

    
 nmlkji

yes  
 nmlkji

no  

 
 
51  Specify total dose:    cGy (rads) 

  Line of Therapy (1) Questions: 36 - 77 

Form 2040 R2.0: Langerhans Cell Histiocytosis Pre-HSCT Data  
Center:  CRID: 

                CIBMTR Form 2040 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 3 / 6



 
 

52  Central nervous system:

    
 nmlkji

yes  
 nmlkji

no  

 
 
53  Specify total dose:    cGy (rads) 

 
 

54  Gastrointestinal tract

    
 nmlkji

yes  
 nmlkji

no  

 
 
55  Specify total dose:    cGy (rads) 

 
 

56  Liver

    
 nmlkji

yes  
 nmlkji

no  

 
 
57  Specify total dose:    cGy (rads) 

 
 

58  Lung:

    
 nmlkji

yes  
 nmlkji

no  

 
 
59  Specify total dose:    cGy (rads) 

 
 

60  Lymph nodes

    
 nmlkji

yes  
 nmlkji

no  

 
 
61  Specify total dose:    cGy (rads) 

 
 

62  Skin

    
 nmlkji

yes  
 nmlkji

no  

 
 
63  Specify total dose:    cGy (rads) 

 
 

64  Spleen

    
 nmlkji

yes  
 nmlkji

no  

 
 
65  Specify total dose:    cGy (rads) 

 
 

66  Other site(s)

    
 nmlkji

yes  
 nmlkji

no  

 
 
67  Specify other site:    

 
 
68  Specify total dose:    cGy (rads) 

 
 

69  Fractionation schedule:

    
 nmlkji

single  
 nmlkji

single daily  
 nmlkji

multiple daily  
 nmlkji

other schedule  

 
 

70  Surgery / Curettage:

    
 nmlkji

yes  
 nmlkji

no  

 
 
71  Specify site(s) of surgery:    

 
 

72  Is surgery report attached?

    
 nmlkji

yes  
 nmlkji

no  

Form 2040 R2.0: Langerhans Cell Histiocytosis Pre-HSCT Data  
Center:  CRID: 

                CIBMTR Form 2040 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 4 / 6



 
 

73  Best response to line of therapy:

    
 nmlkji

CR  Complete response (CR)-absence of all signs and/or symptoms of Langerhans cell histiocytosis 

 nmlkji
PR  Partial Response (PR)-regression of all signs and/or symptoms of disease without appearance of new lesions 

 nmlkji
SD  Stable disease (SD)-persistence of signs and/or symptoms of disease without appearance of new lesions 

 nmlkji
Mixed  Mixed response (Mixed)-regression of some signs and/or symptoms of disease with appearance of new lesions 

 nmlkji
Prog  Progressive disease (PD)-progression of signs and/or symptoms of disease initially detected and/or appearance of new lesions 

 nmlkji
Unknown  

 nmlkji
NE  Not evaluated 

 
 
74  Specify:    

 
 
75  Date response evaluated: __ __ __ __ - __ __- __ __  

 
 

76  Did patient relapse/progress following this line of therapy?

    
 nmlkji

yes  
 nmlkji

no  

 
 
77  Date of relapse/progression: __ __ __ __ - __ __- __ __  

 
 

78  What was the disease status immediately prior to the preparative regimen?

    
 nmlkji

complete response - absence of all signs and/or symptoms of Langerhans cell histiocytosis  

 nmlkji
partial response - regression of signs and/or symptoms of disease without appearance of new lesions  

 nmlkji
stable disease - persistence of signs and/or symptoms of disease without appearance of new lesions  

 nmlkji
mixed response - regression of some signs and/or symptoms of disease with appearance of new lesions  

 nmlkji
progressive disease - progression of signs and/or symptoms of disease initially detected and/or reappearance of old and/or appearance of new lesions  

 nmlkji
unknown / not tested  

 nmlkji
Not evaluable  

 

Specify any organ involvement immediately prior to the preparative regimen: 
 

79  Bone

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

80  Bone Marrow

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

81  Central nervous system

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

82  Gastrointestinal tract

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

83  Liver

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

84  Lung

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

  Disease Status Immediately Prior to the Preparative Regimen Questions: 78 - 92

Form 2040 R2.0: Langerhans Cell Histiocytosis Pre-HSCT Data  
Center:  CRID: 

                CIBMTR Form 2040 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 5 / 6



 
 

85  Lymph nodes

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

86  Skin

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

87  Spleen

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

88  Other organ

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 
89  Specify:    

 
 
90  Specify reason:    

 
 

91  What was the percent of monocytes immediately prior to the preparative regimen?

    
 nmlkji

Known  
 nmlkji

Not known  

 
 
92  .    % 

  
 
First Name:    

 
Last Name:    

  
 
Phone number:    

 
Fax number:    

 
 
E-mail address:    

Form 2040 R2.0: Langerhans Cell Histiocytosis Pre-HSCT Data  
Center:  CRID: 

                CIBMTR Form 2040 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 6 / 6